Rare diseases
Investigational molecules
Locations
Back to Germany2 clinical trials in Celle, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on triple-negative breast cancer and HER2-negative breast cancer, evaluating innovative treatment approaches in both early and advanced stages of the disease.
Investigations combining immunotherapy with traditional chemotherapy regimens, aiming to improve survival rates and treatment outcomes for breast cancer patients.
Groundbreaking studies exploring the effectiveness of atezolizumab in combination with established chemotherapy protocols for breast cancer treatment.
Research focusing on measuring survival rates and analyzing treatment response patterns in advanced breast cancer patients.
Comprehensive research investigating spatial and temporal patterns in breast cancer treatment responses, with particular focus on drug efficacy and resistance mechanisms.
Studies examining therapeutic outcomes in hormone receptor-positive breast cancer patients undergoing first-line treatment.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
